{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:45:14Z","timestamp":1759333514051},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1988,4,1]],"date-time":"1988-04-01T00:00:00Z","timestamp":575856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":10106,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1988,4]]},"DOI":"10.1111\/1523-1747.ep12461062","type":"journal-article","created":{"date-parts":[[2004,7,19]],"date-time":"2004-07-19T22:12:33Z","timestamp":1090275153000},"page":"532-535","source":"Crossref","is-referenced-by-count":37,"title":["Comparison of Hypothalamus-Pituitary-Adrenal Axis Suppression From Superpotent Topical Steroids by Standard Endocrine Function Testing and Gas Chromatographic Mass Spectrometry"],"prefix":"10.1016","volume":"90","author":[{"given":"William L.","family":"Weston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul V.","family":"Fennessey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph.","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henriette.","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John.","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar.","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois.","family":"Huff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Mark.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald.","family":"Gotlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12461062_bb0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.4.5990.203","article-title":"Observations on the systemic effect of topical clobetasol (Dermovate)","volume":"4","author":"Carruthers","year":"1975","journal-title":"Brit Med J"},{"key":"10.1111\/1523-1747.ep12461062_bb0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.1978.tb06180.x","article-title":"Plasma cortisol levels after topical application of diflucortolone valerate (0.3%) or clobetasol (0.05%) in psoriatic subjects","volume":"99","author":"Keczkes","year":"1978","journal-title":"Brit J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2133.1976.tb02277.x","article-title":"Clobetasol ointment compared with dithranol in Lassar's paste in the treatment of psoriasis","volume":"94","author":"Marriott","year":"1976","journal-title":"Brit J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2133.1976.tb02275.x","article-title":"The response of psoriasis to betamethasone valerate and clobetasol propionate","volume":"94","author":"Corbett","year":"1976","journal-title":"Brit J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0030","first-page":"213","article-title":"A comparison of clobetasol 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis","volume":"37","author":"Jacobson","year":"1986","journal-title":"Cutis"},{"key":"10.1111\/1523-1747.ep12461062_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2133.1976.tb02272.x","article-title":"The effect of percutaneously absorbed steroids on hypothalamic-pituitary-adrenal function after intensive use in in-patients","volume":"94","author":"Munro","year":"1976","journal-title":"Brit J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0040","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0190-9622(87)70105-4","article-title":"Superpotent topical steroid treatment of psoriasis vulgaris \u2013 clinical efficacy and adrenal function","volume":"16","author":"Katz","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12461062_bb0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1210\/jcem-28-5-661","article-title":"Cortisol production rate: VIII. Pregnancy","volume":"28","author":"Migeon","year":"1968","journal-title":"J Clin Endo Metab"},{"key":"10.1111\/1523-1747.ep12461062_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0378-4347(00)80867-1","article-title":"Semimicro quantitative analysis of complex urinary steroid mixtures in healthy and diseased states","volume":"306","author":"Pike","year":"1984","journal-title":"J Chromatog"},{"key":"10.1111\/1523-1747.ep12461062_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2133.1976.tb02271.x","article-title":"The use and interpretation of tests for steroid impaired hypothalamic-pituitary-adrenocorticil functions","volume":"94","author":"Landon","year":"1976","journal-title":"Brit J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2133.1976.tb02273.x","article-title":"Measuring adrenal function in out-patients using topical corticosteroids","volume":"94","author":"Sparkes","year":"1976","journal-title":"Brit J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0065","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/adc.57.3.204","article-title":"Endocrine complications of topical and intralesional corticosteroid therapy","volume":"57","author":"Curtis","year":"1982","journal-title":"Arch Dis Childh"},{"key":"10.1111\/1523-1747.ep12461062_bb0070","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0002-9343(79)90444-3","article-title":"Pituitary adrenal recovery following short-term suppression with corticosteroids","volume":"66","author":"Streck","year":"1979","journal-title":"Amer J Med"},{"key":"10.1111\/1523-1747.ep12461062_bb0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.1981.tb00042.x","article-title":"Halogenation and topical corticosteroids: A comparison between the 17-buryrate esters of hydrocorrisone and clobetasone in ointment bases","volume":"104","author":"Allenby","year":"1981","journal-title":"Brit J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0733-8635(18)30955-0","article-title":"The use of topical steroids in psoriasis","volume":"2","author":"Cornell","year":"1984","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/1523-1747.ep12461062_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2133.1976.tb02280.x","article-title":"Atrophy of the skin","volume":"94","author":"Sneddon","year":"1976","journal-title":"Brit J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1976.tb02274.x","article-title":"Corticosteroids and pustular psoriasis","volume":"94","author":"Baker","year":"1976","journal-title":"Brit J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-4362.1979.tb01905.x","article-title":"Steroid addiction","volume":"18","author":"Kligman","year":"1979","journal-title":"Int J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2133.1976.tb02282.x","article-title":"The use of topical steroids of differing potency in the management of the atopic child","volume":"94","author":"Vickers","year":"1976","journal-title":"Brit J Derm"},{"key":"10.1111\/1523-1747.ep12461062_bb0105","first-page":"270","article-title":"Comparison of two application schedules for clobetasol-17-propionate","volume":"62","author":"Harst","year":"1982","journal-title":"Acta Dermatovener (Stockholm)"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X88913073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X88913073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T20:01:47Z","timestamp":1585857707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X88913073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1988,4]]}},"alternative-id":["S0022202X88913073"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12461062","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1988,4]]}}}